Skip to content

DOWNLOAD SELKIRK'S WHITEPAPER ON SAFEGUARDING ASEPTIC FILL FINISH WITH DYNAMIC ACCESS CONTROL

A better way to avoid product contamination during aseptic fill-finish WITH UNIDIRECTIONAL FLOW

Aseptic fill/finish manufacturing is a critical, late-stage step in the process of preparing
injectable drugs, such as vaccines and biological therapeutics, for patient delivery.
A problem with fill-finish contract research organizations (CROs) can be rejected batches, regulatory issues, and unresponsive behavior. 

Whitepaper Dynamic Access

Selkirk Pharma set out with a vision of creating the world’s most reliable fill/finish manufacturer of injectable drug products by incorporating an array of leading-edge technologies to ensure high quality and high yields, which are especially vital for high-value biologic therapeutics.  Among the many innovative design features included in Selkirk’s state-of-the-art premises, dynamic access control serves to achieve a unidirectional flow of personnel. Not only is this essential to avoid product contamination during aseptic fill/finish manufacturing, especially when running multiple fill lines for a diverse selection of products, but it also helps to improve process efficiencies and facilitate product release.

This white paper examines how Selkirk Pharma implemented a dynamic access control solution at its Spokane facility, with rationale for some of the decisions that were made during the planning process. It also highlights the key features and benefits of
programmable logic controller (PLC)-based systems and standard access control, including their applicability to aseptic fill/finish manufacturing.

Fill out the form to the right to download your copy of Selkirk's Pharma whitepaper on Safeguarding Aseptic Fill-Finish with Dynamic Access Control.